Articles from GlycoEra

GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline
Dr. Duda to apply deep expertise in rare and immune-mediated diseases
By GlycoEra · Via GlobeNewswire · January 8, 2026
GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
Financing led by Novo Holdings with significant support from world-class group of existing and new investors
By GlycoEra · Via GlobeNewswire · May 27, 2025